CCR5 antagonist
Jump to navigation
Jump to search
Indications
- adjunctive treatment of HIV1
Mechanism of action
- inhibits entry of HIV1 into cells when HIV1 uses CCR5 to gain entry into cells (50-60% of HIV1 strains)
More general terms
More specific terms
Additional terms
References
- ↑ Prescriber's Letter 14(9): 2007 New Drug: Selzentry (Maraviroc) Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=230904&pb=PRL (subscription needed) http://www.prescribersletter.com